Back
Catalyst Pharmaceuticals, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
60
CPRX
Catalyst Pharmaceuticals, Inc.
Last Price:
$24.43
Seasonality Move:
10.15%
7 Day Trial
ALL ACCESS PASS
$
7
Catalyst Pharmaceuticals, Inc. Stock Forecast
-
Over the next 52 weeks, Catalyst Pharmaceuticals, Inc. has on average historically risen by 35% based on the past 19 years of stock performance.
-
Catalyst Pharmaceuticals, Inc. has risen higher in 9 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 47.37%
-
Is Catalyst Pharmaceuticals, Inc. Stock Undervalued?The current Catalyst Pharmaceuticals, Inc. [CPRX] share price is $24.42. The Score for CPRX is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
CPRX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Catalyst Pharmaceuticals, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Catalyst Pharmaceuticals, Inc. has on average historically risen by 35% based on the past 19 years of stock performance.
Catalyst Pharmaceuticals, Inc. Stock Rating
Buy
60
Catalyst Pharmaceuticals, Inc. (CPRX)
is a Buy
Is Catalyst Pharmaceuticals, Inc. overpriced?
-
Catalyst Pharmaceuticals, Inc. has risen higher in 9 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 47.37%
Catalyst Pharmaceuticals, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
catalystpharma.com
52-Week Data
52-Week High:
26.58
52-Week Low:
19.05
Prediction Charts
Market Cap:
3B
Price in USD:
24.42
Volume:
813K
Beta:
1.05
Technical Analysis
SMA50:
23.77
SMA100:
22.66
SMA200:
22.30
52-Wk Change:
8.39%
Stock Predictions
-
Is Catalyst Pharmaceuticals, Inc. stock public?Yes, Catalyst Pharmaceuticals, Inc. is a publicly traded company.
-
What is the Catalyst Pharmaceuticals, Inc. stock quote today?The Catalyst Pharmaceuticals, Inc. stock price is 24.42 USD today.
-
How to buy Catalyst Pharmaceuticals, Inc. stock online?You can buy Catalyst Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-30 | 24.60 | 24.30 | 24.80 | 24.10 |
| Feb-2 | 24.23 | 25.00 | 25.14 | 24.20 |
| Feb-3 | 24.99 | 25.22 | 25.53 | 24.77 |
| Feb-4 | 25.26 | 25.06 | 25.36 | 24.88 |
| Feb-5 | 25.22 | 23.91 | 25.40 | 23.86 |
| Feb-6 | 24.27 | 24.44 | 24.58 | 23.73 |
| Feb-9 | 24.45 | 24.45 | 24.85 | 24.20 |
| Feb-10 | 24.53 | 24.27 | 24.60 | 24.03 |
| Feb-11 | 24.16 | 23.93 | 24.37 | 23.27 |
| Feb-12 | 23.87 | 23.60 | 24.24 | 23.40 |
| Feb-13 | 23.67 | 24.33 | 24.68 | 23.65 |
| Feb-17 | 24.53 | 24.64 | 24.86 | 24.10 |
| Feb-18 | 24.36 | 24.29 | 24.83 | 24.28 |
| Feb-19 | 24.29 | 24.42 | 24.59 | 24.01 |
Catalyst Pharmaceuticals, Inc. Earnings
Catalyst Pharmaceuticals, Inc. Earnings Report: Per Share Catalyst Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Catalyst Pharmaceuticals, Inc. Forecast Revenue Growth
Catalyst Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Catalyst Pharmaceuticals, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.05 per share, and an increase next year of $0.03 per share.
* Catalyst Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.